Physician profile
Mark P Taylor
NPI 1720067655
$178.52
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.85 · 2020: $27.12 · 2021: $52.23 · 2022: $3.32.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $32.35 | 2019 | |
| Hologic Sales and Service, LLC | $22.57 | 2019 | |
| Davol INC. | $18.42 | 2021 | |
| Olympus America INC. | $17.24 | 2019 | |
| Roche Diagnostics Corporation | $16.10 | 2020 | |
| Abbvie INC. | $13.95 | 2021 | |
| Merck Sharp & Dohme LLC | $12.31 | 2019 | |
| Organon LLC | $11.91 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.38 | 2019 | |
| Myovant Sciences INC. | $11.27 | 2021 | |
| Coopersurgical, INC. | $11.02 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.